 |
 |
 |
|
|
Silex Systems Limited (Silex) established as a research subsidiary
of Sonic Healthcare Limited. |
 |
|
Silex began researching the laser isotope separation ideas of
co-inventors, Dr Michael Goldsworthy and Dr Horst Struve. |
 |
|
The unique principles of the SILEX (Separation of Isotopes by
Laser EXcitation) Process were established. |

|
|
Proof of Principle demonstration of the SILEX Process
was achieved at the Companys laboratories at Lucas Heights,
Sydney. Uranium Enrichment, just one of the possible applications
of SILEX, became the companys initial focus. |

|
|
Silex was divested from Sonic, and later reached agreement for
the development and licensing of SILEX Technology (exclusively
for uranium), with the United States Enrichment Corporation
(USEC, Inc.) |
 |
|
Silex listed on the Australian Stock Exchange on 7 May 1998. |
 |
|
First milestone of the uranium enrichment program achieved
demonstrating the process physics of the Silex concept
at a prototypical level.
Agreement for Co-operation between the United States and Australian
Governments paved the way for continued development of SILEX
Technology for uranium enrichment, facilitating its future
transfer to the US.
A program to develop applications
of SILEX Technology for Silicon, Oxygen and Carbon enrichment (known as the Stable Isotopes Program) was launched.
Silex won the 2000 Australian Technology Award for Excellence
in the Manufacturing and Engineering sector.
Silex secured a "START" R&D Grant from the Australian
Government to fund 50% of the SILEX Stable Isotope Program.
A research agreement signed with Westinghouse Electric Company
to investigate the application of SILEX Technology to the
enrichment of zirconium, (which has the potential to improve
the economics of nuclear power reactors).
Silex raised $36 million to assist in funding the development
of the Companys technology portfolio.
|
 |
|
Silex moved further into the semiconductor technology field
with the acquisition of a 30% interest in Silicon Valley start-up, Translucent Photonics,
Inc. Translucent is developing a revolutionary technology
to create "optical gain" in silicon, potentially
enabling silicon to play a major role in the photonics/optical
communications industry for the first time.
The SILEX Technology was officially "Classified"
by the US and Australian Governments. The implications of
classification relate mainly to security protocols.
|
 |
|
Silex acquired a controlling interest in Fiberbyte Pty Ltd, a laser based optical communications company in Adelaide.
The SILEX Uranium Enrichment Project achieved a key milestone with the first full demonstration of practical uranium enrichment using the SILEX 'Direct Measurment Facility'.
Silex signed a Collaboration Agreement with Sumitomo Mitsubishi Silicon Corporation (SUMCO), the world's second largest
silicon wafer manufacturer, to test enriched silicon wafers for semiconductor applications.
|
 |
|
USEC announced its withdrawal from the uranium project after funding it for six years, despite continuing positive results.
The first batch of enriched silicon-28 arrived at SUMCO's wafer plant in Japan, initiating a program to manufacture enriched silicon wafers.
The SILEX silicon project achieved a key demonstration milestone, with enrichment of silicon-28 to ~99.9% (from ~92% natural essay).
Silex took majority ownership in Translucent Photonics, moving to ~70% interest (from 30%). Silex also increased its stake in Fiberbyte to ~83% (from 51%).
Translucent achieved a key technical milestone by demonstrating optical gain in crystalline silicon material. This milestone could have far reaching implications
for the semiconductor and photonics industries, potentially allowing fully integrated electronic
and optical processing in silicon chips for the first time.
|
 |
|
US based subsidiary Translucent Inc won core patent protection for its invention, receiving official notice of allowance from the United States Patent and Trademark Office. The
Patent "Optical Gain in Silicon" protects not only the core material, but also the device structures which will be fabricated from that material.
Silex commissioned the world’s first silicon laser enrichment pilot plant.
Translucent pursues key ‘spin-off’ technologies (Silicon-on-Insulator (SOI) substrates
and ‘high-k’ dielectrics) with potential application to the silicon chip industry. Silex and
Translucent agree on a ~US$9M debt funding round to accelerate commercialisation
efforts.
|
 |
|
Translucent wins a US Defence Department DARPA Grant of US$1.2M over 4 years, to help develop the ‘optical silicon’ technology, under DARPA’s Electronics and Photonics Integrated Circuits (EPIC) Program.
Results of the first round of enriched silicon wafer tests conducted by SUMCO show
modest improvements in overall semiconductor device performance. Plans for further tests
are outlined.
Subsidiary Fiberyte Pty Ltd wins a Federal Government “Commercial Ready Grant” for its
novel ‘USB-inSync™’ Data Acquisition Technology ($1.15 million over two years).
Translucent’s commercialisation strategy moves forward with 25 Patents/Applications
and third party discussions in progress.
Silex announced the successful completion of its Uranium Enrichment Technology
Evaluation project, the results indicating attractive economics.
Commencement of Due Diligence for the uranium project with several potential
commercial partners. Classified component of Due Diligence process delayed by US
Government approvals.
Translucent achieved a key milestone in its project to develop a silicon-based photonics material – the demonstration of ‘electroluminescence’ at room temperature – an important step in the quest to develop a silicon laser and optical interconnects.
|
 |
|
Silex and the General Electric Company sign an exclusive Commercialisation and License Agreement for the SILEX Uranium Enrichment Technology Technology in May, with US Government authorisations received in October.
Translucent files two provisional patents for the development of its advanced materials in Alternative Energy applications: Ultra high efficiency solar cells and thermoelectric energy conversion.
|
 |
|
The transfer of the SILEX Uranium Enrichment project to GE’s Wilmington, North Carolina nuclear fuel plant was completed in the first half of 2007. This included equipment used in prior work, to be re-deployed in the Test Loop Program, and a team of 12 key Silex staff who joined with the recently form GE team in Wilmington.
GE-Hitachi Signs Letters of Intent for uranium enrichment services and support using the SILEX Technology with Exelon and Entergy - the two largest nuclear power utilities in the US.
Silex successfully completes a $50 million placement of new securities to professional and sophisticated shareholders. The placement closed heavily oversubscribed.
|
 |
|
Global Laser Enrichment (GLE), formed as a subsidiary of GE Hitachi Nuclear Energy (GEH) to commercialise
the SILEX Technology, announced that it had selected its Wilmington, N.C., headquarters site for the first
potential commercial SILEX uranium enrichment facility.
GLE was notified that the U.S. Nuclear Regulatory Commission (NRC) approved a license amendment (to
an existing nuclear facility license) to operate the Test Loop for the next generation SILEX laser enrichment
technology.
GE Hitachi Nuclear Energy (GEH) and Cameco Corp. (NYSE:CCJ) announced that Cameco Corporation, the
world’s largest uranium producer, had joined GE and Hitachi as owners of their laser enrichment venture GLE.
Cameco paid US$123.8 million for a 24% stake in GLE.
|
 |
|
|